title: QTc prolongation with asenapine.
authors.affiliation: University of Adelaide, Adelaide, Australia.
authors.forename: Felix
authors.initials: F
authors.lastname: Kotasek
authors.affiliation: The Queen Elizabeth Hospital, Woodville, South Adelaide, Australia prashant.tibrewal@health.sa.gov.au.
authors.forename: Prashant
authors.initials: P
authors.lastname: Tibrewal
authors.affiliation: The Queen Elizabeth Hospital, Woodville, South Adelaide, Australia.
authors.forename: Rohan
authors.initials: R
authors.lastname: Dhillon
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects*; D003986:Dibenzocycloheptenes; D006576:Heterocyclic Compounds, 4 or More Rings / Q000009:adverse effects*; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D003986:Dibenzocycloheptenes; D006576:Heterocyclic Compounds, 4 or More Rings; C522667:asenapine